Cantor Fitzgerald Boosts Envision Healthcare (EVHC) Price Target to $40.00
Envision Healthcare (NYSE:EVHC) had its price target raised by Cantor Fitzgerald from $37.00 to $40.00 in a research note released on Wednesday morning. The firm currently has a neutral rating on the stock.
EVHC has been the subject of several other reports. ValuEngine downgraded shares of Envision Healthcare from a buy rating to a hold rating in a report on Sunday, December 31st. Mizuho set a $57.00 price target on shares of Envision Healthcare and gave the stock a hold rating in a report on Tuesday, October 31st. Citigroup downgraded shares of Envision Healthcare from a buy rating to a neutral rating and set a $31.00 price target for the company. in a report on Thursday, November 2nd. KeyCorp lowered their price target on shares of Envision Healthcare from $67.00 to $37.00 and set an overweight rating for the company in a report on Thursday, November 2nd. Finally, Credit Suisse Group started coverage on shares of Envision Healthcare in a report on Monday, December 11th. They set an outperform rating and a $36.00 price target for the company. One research analyst has rated the stock with a sell rating, eight have assigned a hold rating and nine have issued a buy rating to the stock. The company currently has an average rating of Hold and a consensus target price of $42.23.
Envision Healthcare (EVHC) opened at $40.05 on Wednesday. The stock has a market cap of $4,841.60, a price-to-earnings ratio of 14.83, a PEG ratio of 1.01 and a beta of 0.48. The company has a debt-to-equity ratio of 0.89, a quick ratio of 3.00 and a current ratio of 3.01. Envision Healthcare has a 1-year low of $23.77 and a 1-year high of $69.21.
A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Stonebridge Capital Management Inc. boosted its position in Envision Healthcare by 87.0% during the third quarter. Stonebridge Capital Management Inc. now owns 30,329 shares of the company’s stock valued at $1,364,000 after acquiring an additional 14,111 shares during the last quarter. CI Investments Inc. bought a new stake in Envision Healthcare during the third quarter valued at $9,084,000. Wells Fargo & Company MN boosted its position in Envision Healthcare by 11.2% during the third quarter. Wells Fargo & Company MN now owns 917,418 shares of the company’s stock valued at $41,238,000 after acquiring an additional 92,339 shares during the last quarter. OZ Management LP bought a new stake in Envision Healthcare during the third quarter valued at $131,987,000. Finally, Hexavest Inc. boosted its position in Envision Healthcare by 1.1% during the fourth quarter. Hexavest Inc. now owns 655,516 shares of the company’s stock valued at $22,655,000 after acquiring an additional 7,270 shares during the last quarter.
About Envision Healthcare
Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.
Receive News & Ratings for Envision Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.